Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography
- PMID: 1574997
- DOI: 10.1111/j.1600-0404.1992.tb04021.x
Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography
Abstract
The intracerebral kinetics of [11C]-labelled L-3,4-dihydroxyphenylalanine, L-DOPA, was investigated in rhesus monkeys by positron emission tomography (PET). Through the labelling of the L-DOPA molecule in different positions and observation of a series of pharmacological challenges it was possible to establish that the kinetic conversion of the radiotracer in the striatum represents the process of decarboxylation to [11C]-labelled dopamine. The rate constant for this process can be estimated using a two-compartment model. The use of [11C]-L-DOPA and PET will thus provide a possibility for in vivo studies of blood-brain barrier transport of the amino acid as well as for the estimation of the ability for brain tissue to decarboxylate the tracer by the action of aromatic L-amino acid decarboxylase.
Similar articles
-
A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.J Cereb Blood Flow Metab. 1999 Oct;19(10):1142-9. doi: 10.1097/00004647-199910000-00011. J Cereb Blood Flow Metab. 1999. PMID: 10532639
-
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.Psychiatry Res. 1992 Nov;45(3):153-68. doi: 10.1016/0925-4927(92)90023-w. Psychiatry Res. 1992. PMID: 1283014
-
Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response.Acta Neurol Scand. 1992 Feb;85(2):95-102. doi: 10.1111/j.1600-0404.1992.tb04005.x. Acta Neurol Scand. 1992. PMID: 1574995
-
Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.Synapse. 1998 May;29(1):37-61. doi: 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C. Synapse. 1998. PMID: 9552174 Review.
-
Biological imaging and the molecular basis of dopaminergic diseases.Biochem Pharmacol. 1997 Aug 1;54(3):341-8. doi: 10.1016/s0006-2952(97)00031-2. Biochem Pharmacol. 1997. PMID: 9278092 Review.
Cited by
-
Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on in vivo L-[beta-11C]dopa turnover in the rat striatum with infusion of L-tyrosine.J Neural Transm Gen Sect. 1994;95(1):1-15. doi: 10.1007/BF01283026. J Neural Transm Gen Sect. 1994. PMID: 7857582
-
A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.Psychopharmacology (Berl). 2004 Feb;171(4):365-74. doi: 10.1007/s00213-003-1672-y. Epub 2003 Dec 11. Psychopharmacology (Berl). 2004. PMID: 14668973 Review.
-
Central action of benserazide after COMT inhibition demonstrated in vivo by PET.J Neural Transm Gen Sect. 1991;85(1):11-7. doi: 10.1007/BF01244653. J Neural Transm Gen Sect. 1991. PMID: 1867835
-
Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brain.J Neural Transm Gen Sect. 1993;94(2):127-35. doi: 10.1007/BF01245006. J Neural Transm Gen Sect. 1993. PMID: 8110439
-
Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.J Neurosci. 2000 Sep 15;20(18):7067-73. doi: 10.1523/JNEUROSCI.20-18-07067.2000. J Neurosci. 2000. PMID: 10995853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources